Effects of endothelin on neuroeffector junction in mesenteric arteries of hypertensive rats.
- 1 June 1990
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 15 (6_pt_2) , 739-743
- https://doi.org/10.1161/01.hyp.15.6.739
Abstract
The effect of endothelin, a novel vasoconstrictor peptide, on the adrenergic neuroeffector junction was investigated in isolated perfused mesenteric arteries of spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. The vasoconstrictor responses to periarterial sympathetic nerve stimulation and exogenous norepinephrine were determined. Infusion of endothelin-1 increased the baseline perfusion pressure dose dependently to similar extents in the two strains. A subpressor dose of endothelin-1 (10(-10) M) enhanced the pressor response to norepinephrine; its effect was greater in WKY rats than in SHR. Endothelin-1 (10(-12) to 10(-10) M) attenuated the pressor response to sympathetic nerve stimulation, and the degree of inhibition tended to be less in SHR than in WKY rats. Higher doses (3 x 10(-10) and 10(-9) M) of endothelin-1 enhanced the pressor response to nerve stimulation in both WKY rats and SHR. Endothelin-1 inhibited norepinephrine release from rat mesenteric arteries; the inhibition was significantly less in SHR than in WKY rats. These results suggest that endothelin enhances the responsiveness of alpha-adrenergic receptors to catecholamines, whereas it inhibits presynaptic adrenergic neurotransmission. Thus, endothelin can interact with the neuroeffector junction in addition to having a vasoconstricting effect in peripheral vessels. The difference in the mode of modulation by endothelin at the vascular neuroeffector junction in SHR from that in WKY rats might explain the maintenance of hypertension.Keywords
This publication has 19 references indexed in Scilit:
- Endothelin inhibits presynaptic adrenergic neurotransmission in rat mesenteric arteryBiochemical and Biophysical Research Communications, 1989
- The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.Proceedings of the National Academy of Sciences, 1989
- Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteriesBiochemical and Biophysical Research Communications, 1989
- Effects of Endothelin-1 and Endothelin-3 on Blood Pressure in Conscious Hypertensive RatsJournal of Cardiovascular Pharmacology, 1989
- Endothelin action: Inhibition by a protein kinase C inhibitor and involvement of phosphoinositolsBiochemical and Biophysical Research Communications, 1989
- Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilizationBiochemical and Biophysical Research Communications, 1989
- Inhibition of adrenergic neuroeffector transmission by endothelin in the guinea‐pig femoral arteryActa Physiologica Scandinavica, 1988
- Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto ratsEuropean Journal of Pharmacology, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Inositol trisphosphate, a novel second messenger in cellular signal transductionNature, 1984